Using primary cultures of myofibroblasts established from normal human esophagus in in vitro models of GERD injury [5] we have previously demonstrated that myofibroblasts stimulated with acid and toll-like receptor 4 (TLR4) agonists increase secretion of IL-6. This evidence concerns the gene IL6 and gastroesophageal reflux disease.